Correlation between miR-223 and IL-35 and their regulatory effect in children with allergic rhinitis

Gaixiang Ruan1, Xiangling Wen1, Zhenwen Yuan1

  • 1E.N.T. Department, the Second People's Hospital, Qilin West Road, Qujing 655000, Yunnan, China.

Insights

MicroRNA-223 (miR-223) and IL-35 levels are altered in allergic rhinitis (AR). Increased miR-223 and decreased IL-35 correlate with AR severity, suggesting potential therapeutic targets.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • The role of microRNAs (miRNAs) in immune responses, particularly in allergic rhinitis (AR), is not fully understood.
  • Interleukin-35 (IL-35) is an immunosuppressive cytokine, but its specific involvement in AR pathogenesis requires further investigation.

Purpose of the Study:

  • To investigate the correlation between serum miR-223 levels and IL-35 in children diagnosed with allergic rhinitis.
  • To explore the relationship between miR-223, IL-35, and clinical indicators of AR severity, including eosinophil counts and Total Nasal Symptom Score (TNSS).

Main Methods:

  • Serum samples were collected from 37 children with AR and 30 healthy controls.
  • Quantitative analysis was performed to measure serum levels of miR-223 and IL-35.
  • Correlations were assessed between miR-223, IL-35, eosinophil cationic protein (ECP), eosinophil counts, TNSS, and Th1/Th2 cytokines.

Main Results:

  • Serum miR-223 levels were elevated, while IL-35 levels were decreased in children with AR compared to healthy controls.
  • A significant inverse correlation was observed between IL-35 and eosinophil markers (ECP, eosinophils), whereas miR-223 showed a positive correlation.
  • Both miR-223 and IL-35 levels correlated with clinical severity scores (TNSS) and Th1/Th2 cytokine profiles.

Conclusions:

  • miR-223 and IL-35 exhibit altered expression patterns in allergic rhinitis, suggesting their involvement in the disease's immune activity.
  • The findings highlight miR-223 and IL-35 as potential biomarkers and molecular targets for developing novel therapeutic strategies for AR.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
934